These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 6607289

  • 1. The third complement factor (C3) and its in vivo cleavage products: interaction with lectins and precipitation with polyethylene glycol.
    Teisner B, Hau J, Svehag SE, Brandslund I, Bøg-Hansen TC.
    J Immunol Methods; 1984 Jan 20; 66(1):113-8. PubMed ID: 6607289
    [Abstract] [Full Text] [Related]

  • 2. Partial characterization of physiologically generated C3 components expressing C3d but not C3c epitopes.
    Siersted HC, Jensenius JC, Svehag SE, Brandslund I.
    J Clin Lab Immunol; 1983 Dec 20; 12(4):201-8. PubMed ID: 6198522
    [Abstract] [Full Text] [Related]

  • 3. Circulating C3, C4, and C3 split products (C3c and C3d) during normal pregnancy.
    Teisner B, Hau J, Tucker M, Lahood J, Grudzinskas JG.
    Am J Reprod Immunol (1980); 1982 Dec 20; 2(6):309-11. PubMed ID: 6984294
    [Abstract] [Full Text] [Related]

  • 4. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE, Harrison RA, Lachmann PJ.
    J Immunol; 1984 Apr 20; 132(4):1960-6. PubMed ID: 6607952
    [Abstract] [Full Text] [Related]

  • 5. Heterogeneity in electrophoretic mobility of C3-derived molecules expressing D but not C-epitopes following in vivo activation of the complement system.
    Teisner B, Brandslund I, Hau J, Svehag SE.
    Acta Pathol Microbiol Immunol Scand C; 1983 Feb 20; 91(1):85-7. PubMed ID: 6191520
    [Abstract] [Full Text] [Related]

  • 6. Interaction of fibronectin with complement component C3.
    Hautanen A, Keski-Oja J.
    Scand J Immunol; 1983 Mar 20; 17(3):225-30. PubMed ID: 6402811
    [Abstract] [Full Text] [Related]

  • 7. Development and clinical application of electroimmunoassays for the direct quantification of the complement C3 split products C3c and C3d.
    Brandslund I, Teisner B, Hyltoft Petersen P, Svehag SE.
    Scand J Clin Lab Invest Suppl; 1984 Mar 20; 168():57-73. PubMed ID: 6333715
    [Abstract] [Full Text] [Related]

  • 8. Demonstration of antigenic determinants specific for the split products of the third complement factor, C3.
    Sinosich MJ, Best N, Teisner B, Grudzinskas JG.
    J Immunol Methods; 1982 Mar 20; 51(3):355-8. PubMed ID: 6180028
    [Abstract] [Full Text] [Related]

  • 9. Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c.
    Garred P, Mollnes TE, Lea T, Fischer E.
    Scand J Immunol; 1988 Mar 20; 27(3):319-27. PubMed ID: 2451273
    [Abstract] [Full Text] [Related]

  • 10. Measurement of C3 conversion by ELISA estimation of neo-determinants on the C3d moiety.
    Holmskov-Nielsen U, Jensenius JC, Teisner B, Erb K.
    J Immunol Methods; 1986 Nov 20; 94(1-2):1-6. PubMed ID: 2431062
    [Abstract] [Full Text] [Related]

  • 11. The quantitation of C3d by routine methods after the direct absorption of human plasma with anti-C3c.
    Mlynek Y, Nilsson M.
    Acta Pathol Microbiol Immunol Scand C; 1985 Oct 20; 93(5):195-8. PubMed ID: 3936336
    [Abstract] [Full Text] [Related]

  • 12. A simple method for quantitative measurement of C3d in human plasma.
    Bhakdi S, Roth M, Nürnberger W.
    J Immunol Methods; 1984 Nov 16; 74(1):79-86. PubMed ID: 6438236
    [Abstract] [Full Text] [Related]

  • 13. Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.
    Lachmann PJ, Pangburn MK, Oldroyd RG.
    J Exp Med; 1982 Jul 01; 156(1):205-16. PubMed ID: 6177820
    [Abstract] [Full Text] [Related]

  • 14. Influence of C3 level on the determination of C3d in plasma and synovial fluid by radial immunodiffusion.
    Hack CE, Paardekooper J, Hannema AJ.
    J Immunol Methods; 1986 Feb 12; 86(2):191-8. PubMed ID: 3080529
    [Abstract] [Full Text] [Related]

  • 15. Charge and size heterogeneity of C3d following in vivo and in vitro activation of the complement system.
    Teisner B, Hau J, Folkersen J, Jepsen HH.
    Complement; 1984 Feb 12; 1(1):36-43. PubMed ID: 6085760
    [Abstract] [Full Text] [Related]

  • 16. Quantification of the C3d split products of human complement by a sensitive enzyme-linked immunosorbent assay.
    Mollnes TE.
    Scand J Immunol; 1985 Jun 12; 21(6):607-13. PubMed ID: 3895396
    [Abstract] [Full Text] [Related]

  • 17. Acute complement activation during an anaphylactoid reaction to blood transfusion and the disappearance rate of C3c and C3d from the circulation.
    Teisner B, Brandslund I, Grunnet N, Hansen LK, Thellesen J, Svehag SE.
    J Clin Lab Immunol; 1983 Oct 12; 12(2):63-7. PubMed ID: 6606048
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
    Aguado MT, Lambris JD, Tsokos GC, Burger R, Bitter-Suermann D, Tamerius JD, Dixon FJ, Theofilopoulos AN.
    J Clin Invest; 1985 Oct 12; 76(4):1418-26. PubMed ID: 2932466
    [Abstract] [Full Text] [Related]

  • 19. Plasma C3d/C3 quotient as a parameter for in vivo complement activation.
    Nürnberger W, Bhakdi S.
    J Immunol Methods; 1984 Nov 16; 74(1):87-91. PubMed ID: 6334115
    [Abstract] [Full Text] [Related]

  • 20. Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma.
    Brandslund I, Siersted HC, Svehag SE, Teisner B.
    J Immunol Methods; 1981 Nov 16; 44(1):63-71. PubMed ID: 6166689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.